絞り込み

16645

広告

【動画】「cough medicine」を説明してみよう (日経BP)

診察室やカンファレンスなどでよく使う医療英語のエッセンスを、今日も楽しく学んでいきましょう。 今日のレッスンも「説明力トレーニング」です。「この薬って何ですか?...

  1. 入学定員減は 医学生の学力低下が背景に?...
  2. 心電図の新たな名著になるかもしれない書籍...
  3. マスクが足りない!医療機関でも深刻な事態...
  4. 新型コロナウイルス対応まっただ中の保健所...

ニュース一覧

Evolution of thrombin formation and fibrinolysis markers, including thrombin-activatable fibrinolysis inhibitor, during severe meningococcemia.

著者 Fouassier M , Moreau D , Thiollière F , Frère C , Marquès-Verdier A , Souweine B
Pathophysiol Haemost Thromb.2005 ; 34(6):284-7.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (14view , 0users)

Full Text Sources

Medical

A 17-year-old girl presented with Neisseria meningitidis sepsis, with evidence of disseminated intravascular coagulation. Substitution therapy with both antithrombin and protein C concentrates was initiated, leading to clinical and biological improvement. Sequential dosages were performed for biological markers including thrombin-activatable fibrinolysis inhibitor (TAFI). Substitution therapy with both antithrombin and protein C concentrates led to a clinical and biological improvement. Biological markers showed a decrease in thrombin generation and in plasminogen activator inhibitor 1 (PAI-1) and a return of TAFI to a normal value. Discontinuation of substitutive treatment was marked by a clinical relapse at 24 h, with thrombin generation and increase in PAI-1, while TAFI remained unchanged. This report shows the evolution of hemostasis markers during septic shock and provides new data concerning the effects of a substitutive therapy.
PMID: 16772741 [PubMed - indexed for MEDLINE]
印刷用ページを開く Endnote用テキストダウンロード